Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report

Complications - [d] Vascular Disease and Anti-Hypertensive Therapy

Data on age, BMI, diabetes duration, gender, initial visit, indigenous status, currently pregnant individuals, smoking status and type of diabetes by treatment

Page last updated: December 2011

Finally, Table 28 shows the analysis of the Blood Pressure levels [Target ≤ 130/80] and Anti-Hypertensive Therapy [AntiHT Rx] status of individuals reported to have ever had Vascular Disease [Myocardial Infarct, CABG/Angioplasty or Stroke]. Of 837 individuals, 50.8% were above target despite 94.4% receiving Therapy [mean BP 146/76] and 5.6% not on BP Rx!.

Table 28 Vascular Disease and Anti-Hypertensive Rx [Adult Forms Only]

BPAntiHT RxN% in Category%Mean BP [Mean SD]
BP > 130/80
No
24
5.6
142 13 / 79 10
Yes
401
94.4
146 15 / 76 11
Total
425
100.0
50.8
BP ≤ 130/80
No
44
10.7
117 9 / 66 8
Yes
368
89.3
118 10 / 68 8
Total
412
49.2
837
100.0

Document download

This publication is available as a downloadable document.

Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)